Xinyan Jin

机构：Shanghai University of Traditional Chinese Medicine, Shanghai Traditional Chinese Medicine Hospital, Central Hospital of Putuo District, First Affiliated Hospital Zhejiang University

发表论文 10 篇 · 总被引 131 次 · h-index 4

代表论文

• Oncolytic virus VG161 in refractory hepatocellular carcinoma (2025 · Nature · 被引 82)
• The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review (2025 · Drug Design Development and Therapy · 被引 16)
• Nanosecond pulsed electric field ablation‐induced modulation of sphingolipid metabolism is associated with Ly6c2 + mononuclear phagocyte differentiation in liver cancer (2023 · Molecular Oncology · 被引 14)
• Clinical outcomes from a phase I clinical trial of a novel oncolytic virus VG161 in patients with hepatocellular carcinoma (HCC) refractory after 2 prior lines of therapy including checkpoint inhibitors (CPI). (2024 · Journal of Clinical Oncology · 被引 10)
• Effectiveness and safety of dolutegravir plus lamivudine in treating HIV in China, including outcomes of patients coinfected with tuberculosis (2024 · Medicine · 被引 3)
• 766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer (2023 · Regular and Young Investigator Award Abstracts · 被引 3)